To determine the involvement of PKC in the phosphorylation of ezrin in canine OSA, the WHA was performed on four patient-derived ezrin-expressing canine OSA cell lines treated with specific small-molecule inhibitor of PKC [82]. The gene discussed is PRRT2; the disease is obstructive sleep apnea syndrome.